Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)

NCT02817789 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Aortic Valve Stenosis

Interventions

DRUG: Ticagrelor alone
DRUG: Combination lysine acetylsalicylate - clopidogrel

Sponsor

University Hospital, Bordeaux